KENDLE INTERNATIONAL OFFERS EXPANDED ACCESS TO CLINICAL TRIAL PATIENTS THROUGH NEW OPERATION IN INDIA

Kendle, a leading, global full-service clinical research organization, today announced the opening of an office in New Delhi, India, further expanding its access to large patient populations in the Asia/Pacific region. The new location will provide full-service Phase I-IV clinical development solutions for biopharmaceutical companies conducting trials in India.

BioSpace (http://www.biospace.com/news_story.cfm?StoryID=18695120&full=1)